Pfizer’s Tanezumab REMS Cannot Make Benefit-Risk Positive, US FDA Panel Says

 
• By Sue Sutter
shutterstock 18043132 Hawaii - Oct. 24: A surfboard explodes beneath surfer Ezra Sitt's feet when he hits the lip of the wave Oct.24, 2007 at Rocky Point, Hawaii. This is a great example of a freak accident while surfing. M By Mana Photo
Tanezumab wiped out at its advisory committee meeting for use in osteoarthritis.

More from US FDA Performance Tracker

More from Regulatory Trackers